Cargando…
Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
Autores principales: | Eiger, Daniel, Brandão, Mariana, de Azambuja, Evandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078694/ https://www.ncbi.nlm.nih.gov/pubmed/32188717 http://dx.doi.org/10.1136/esmoopen-2020-000688 |
Ejemplares similares
-
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
por: Bartsch, Rupert, et al.
Publicado: (2018) -
SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017) -
The Exciting New Field of HER2-Low Breast Cancer Treatment
por: Eiger, Daniel, et al.
Publicado: (2021) -
Post SABCS local therapy and radiology
por: Fitzal, Florian
Publicado: (2018) -
SABCS 2017 pathology: from bench to bedside
por: Bago-Horvath, Zsuzsanna
Publicado: (2018)